Healthy Adult Male and Female Volunteers

1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Centessa Pharmaceuticals
1 program
1
ORX489 TabletsPhase 11 trial
Active Trials
NCT07413666Recruiting212Est. Jun 2027

Trial Timeline

Clinical trial activity over time

2026
2027
Centessa PharmaceuticalsORX489 Tablets

Clinical Trials (1)

Total enrollment: 212 patients across 1 trials

NCT07413666Centessa PharmaceuticalsORX489 Tablets

A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years

Start: Feb 2026Est. completion: Jun 2027212 patients
Phase 1Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 212 patients
1 companies competing in this space